000786:SZSEBeijing New Building Materials Public Limited Company Analysis
Data as of 2026-08-01 - not real-time
CN¥19.28
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical snapshot: The stock trades below its 20‑day and 50‑day moving averages, signaling a bearish price bias, while the MACD has turned bullish and the RSI sits around the midpoint, suggesting no immediate overbought pressure. Volatility is elevated, yet the beta is notably low, indicating limited systematic market risk. Fundamentally, the price sits above the discounted cash‑flow estimate, making the equity appear overvalued relative to intrinsic calculations, but the dividend yield remains attractive and the payout ratio is comfortably below the cash‑flow generation threshold. The company’s margins are solid, cash balances exceed debt, and free cash flow supports the dividend, though revenue growth is slightly negative.
Outlook: Given the bearish technical backdrop and the premium pricing versus intrinsic value, short‑term pressure may persist, but the strong dividend and low beta provide a defensive cushion. Over the medium horizon, the valuation gap narrows as earnings are expected to improve, while the long‑run case hinges on a turnaround in revenue growth and continued cash‑flow strength.
Outlook: Given the bearish technical backdrop and the premium pricing versus intrinsic value, short‑term pressure may persist, but the strong dividend and low beta provide a defensive cushion. Over the medium horizon, the valuation gap narrows as earnings are expected to improve, while the long‑run case hinges on a turnaround in revenue growth and continued cash‑flow strength.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below short‑term moving averages
- overvalued relative to DCF
- high short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- attractive dividend yield
- stable cash‑flow generation
- moderate valuation gap
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- low beta providing defensive profile
- potential earnings improvement
- sustainable dividend policy
Key Metrics & Analysis
Financial Health
Revenue Growth-1.30%
Profit Margin11.38%
P/E Ratio11.4
ROE10.43%
ROA5.45%
Debt/Equity2.76
P/B Ratio1.2
Op. Cash FlowCN¥3.8B
Free Cash FlowCN¥1.7B
Industry P/E30.9
Technical Analysis
TrendBearish
RSI50.0
SupportCN¥16.53
ResistanceCN¥20.65
MA 20CN¥18.61
MA 50CN¥19.90
MA 200CN¥24.23
MACDBullish
VolumeStable
Fear & Greed Index92.88
Valuation
Fair ValueCN¥14.51
Target PriceCN¥29.96
Upside/Downside55.41%
GradeOvervalued
TypeValue
Dividend Yield3.55%
Risk Assessment
Beta0.14
Volatility41.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.